Hepatitis C: The silent epidemicNDTVLast year, she donated blood at a mobile blood camp, but was not told anything was wrong. She learnt she had Hepatitis C only this year when she donated blood at the AIIMS Trauma Centre because the centre followed a …
HIV drugs may get new role in fighting cancer – Reuters India
HIV drugs may get new role in fighting cancerReuters IndiaCiti said it expected vicriviroc to re-enter clinical testing in combination with cancer immunotherapy as Merck explores its potential across multiple tumor types, including melanoma, colorectal…
AbbVie Inc (ABBV): AbbVie's CEO Discusses Q3 2013 Results – Earnings Call … – Seeking Alpha
|
AbbVie Inc (ABBV): AbbVie’s CEO Discusses Q3 2013 Results – Earnings Call …
Seeking Alpha In addition to assets currently in late-stage such as HCV, daclizumab, elagolix, (inaudible) and elotuzumab were on the cusp of transitioning several additional programs in the Phase 3 development, including but not limited to ABT-199 per CLL and ABT … |
No plans for the weekend? Here are some options – Elmira Star-Gazette
|
No plans for the weekend? Here are some options
Elmira Star-Gazette The re-installation of the Clemens Center’s Marr and Colton theater organ will be celebrated Sunday with a vintage silent movie accompanied by organ virtuoso David Peckham. The 1925 classic ‘The Phantom of the Opera’ starring Lon Chaney will begin at 4 … |
What's Behind AbbVie's Rocking Q3 Earnings – DailyFinance
Jutia Group |
What’s Behind AbbVie’s Rocking Q3 Earnings
DailyFinance AbbVie’s partnership with Biogen Idec on daclizumab also looks promising. The drug targets treatment of patients with relapsed or remitting multiple sclerosis. Daclizumab is currently in a late-stage study. AbbVie and Biogen expect that study to wrap … AbbVie Inc (ABBV): AbbVie’s CEO Discusses Q3 2013 Results – Earnings Call …Seeking Alpha AbbVie Reports Third-Quarter 2013 Financial ResultsMarketWatch |
Infinity Pharmaceuticals Inc. (INFI): Infinity Pharmaceuticals Presents A … – Seeking Alpha
Infinity Pharmaceuticals Inc. (INFI): Infinity Pharmaceuticals Presents A …Seeking AlphaThis recommendation was based on a predefined interim analysis showing highly statistically significant efficacy for the primary endpoint of progression-free surv…
Is Israel an Apartheid State? – CounterPunch
|
Is Israel an Apartheid State?
CounterPunch Please, use our brand new secure shopping cart to make a tax-deductible donation to CounterPunch today or purchase a subscription and a gift sub for someone or one of our award winning books (or a crate of books!) as holiday presents. (We won’t call … |
New Treatment Potential for Severe Asthma Patients – Science Daily (press release)
|
New Treatment Potential for Severe Asthma Patients
Science Daily (press release) Oct. 25, 2013 — New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids. In a study published today in the journal Nature Communications, researchers from the RIKEN Center for Integrative Medical … |
Stem cell transplants may harm recipient's sex life – 14 News WFIE Evansville
|
Stem cell transplants may harm recipient’s sex life
14 News WFIE Evansville Writing in the Oct. 24 issue of Blood, researchers say that while stem cell transplant was once tied to a high risk of death, survival rates have steadily risen and there’s now more focus on the patients’ quality of life, including their sexual well … |
What's Behind AbbVie's Rocking Q3 Earnings – Motley Fool
Jutia Group |
What’s Behind AbbVie’s Rocking Q3 Earnings
Motley Fool AbbVie’s partnership with Biogen Idec (NASDAQ: BIIB ) on daclizumab also looks promising. The drug targets treatment of patients with relapsed or remitting multiple sclerosis. Daclizumab is currently in a late-stage study. AbbVie and Biogen expect that … AbbVie Inc (ABBV): AbbVie’s CEO Discusses Q3 2013 Results – Earnings Call …Seeking Alpha AbbVie Reports Third-Quarter 2013 Financial ResultsMarketWatch |